Savara
SVRA
#5826
Rank
NZ$1.83 B
Marketcap
NZ$8.96
Share price
-2.10%
Change (1 day)
84.60%
Change (1 year)

Earnings for Savara (SVRA)

Earnings in 2025 (TTM): -NZ$0.2 Billion

According to Savara's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$0.17 Billion a decrease over its 2023 earnings that were of -NZ$95.35 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara from 2002 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.2 Billion19.3%
2024 -NZ$0.17 Billion75.29%
2023 -NZ$95.35 Million43.38%
2022 -NZ$66.5 Million-11.31%
2021 -NZ$74.98 Million-13.3%
2020 -NZ$86.49 Million-36.53%
2019 -NZ$0.14 Billion13.76%
2018 -NZ$0.12 Billion105.54%
2017 -NZ$58.28 Million34.11%
2016 -NZ$43.46 Million-37.43%
2015 -NZ$69.45 Million38.81%
2014 -NZ$50.04 Million33.62%
2013 -NZ$37.45 Million38.49%
2012 -NZ$27.04 Million24.59%
2011 -NZ$21.71 Million-36.5%
2010 -NZ$34.18 Million-3.14%
2009 -NZ$35.29 Million-23.28%
2008 -NZ$45.99 Million8.52%
2007 -NZ$42.38 Million-34.14%
2006 -NZ$64.35 Million184.43%
2005 -NZ$22.63 Million90.75%
2004 -NZ$11.87 Million190.35%
2003 -NZ$4.09 Million11.64%
2002 -NZ$3.66 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-NZ$0.28 Billion 37.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$31.65 Million-84.30%๐Ÿ‡บ๐Ÿ‡ธ USA